1. Home
  2. Analysis
  3. Neulasta
  4. Mvasi

Neulasta and Mvasi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Neulasta (pegfilgrastim) and Mvasi (bevacizumab-awwb). Common drug interactions include neuropathy peripheral among females and neuropathy peripheral among males.

The phase IV clinical study analyzes what interactions people have when they take Neulasta and Mvasi. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Neulasta?

Neulasta has active ingredients of pegfilgrastim. It is often used in agranulocytosis. eHealthMe is studying from 92,286 Neulasta users. Check the latest studies of Neulasta.

What is Mvasi?

Mvasi has active ingredients of bevacizumab-awwb. eHealthMe is studying from 3,295 Mvasi users. Check the latest studies of Mvasi.

On Jul, 13, 2026

45 people who take Neulasta and Mvasi together, and have interactions are studied.

Neulasta and Mvasi drug interactions.

What are the common drug interactions of Neulasta and Mvasi, by gender? *:

female:

  1. Neuropathy peripheral (surface nerve damage)
  2. Nausea (feeling of having an urge to vomit)
  3. Constipation
  4. Dizziness
  5. Macule (a discoloured spot on the skin)
  6. Ovarian cancer (cancer of ovary)
  7. Postoperative wound infection
  8. Proteinuria (presence of protein in the urine)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Abdominal pain

male:

  1. Neuropathy peripheral (surface nerve damage)
  2. Abdominal pain
  3. Cough
  4. Cushing's syndrome (obesity, a rounded face, increased fat)
  5. Dyspnoea (difficult or laboured respiration)
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Pyrexia (fever)
  8. Diarrhoea
  9. Herpes zoster
  10. Hyperhidrosis (abnormally increased sweating)

What are the common drug interactions of Neulasta and Mvasi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Malaise (a feeling of general discomfort or uneasiness)

50-59:

  1. Neuropathy peripheral (surface nerve damage)
  2. Abdominal pain
  3. Constipation
  4. Hyperhidrosis (abnormally increased sweating)
  5. Nausea (feeling of having an urge to vomit)
  6. Macule (a discoloured spot on the skin)
  7. Ovarian cancer (cancer of ovary)
  8. Proteinuria (presence of protein in the urine)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Chest pain

60+:

  1. Neuropathy peripheral (surface nerve damage)
  2. Abdominal pain
  3. Haematochezia (passage of stools containing blood)
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Platelet count decreased
  6. Vomiting
  7. Dysgeusia (disorder of the sense of taste)
  8. Diarrhoea
  9. Nausea (feeling of having an urge to vomit)
  10. Herpes zoster

* Approximation only. Some reports may have incomplete information.

Do you take Neulasta and Mvasi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Neulasta and Mvasi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Neulasta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mvasi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neulasta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mvasi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on pegfilgrastim and bevacizumab-awwb (the active ingredients of Neulasta and Mvasi, respectively), and Neulasta and Mvasi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.